Bora Pharmaceuticals is a premier, international, cGMP CDMO specializing in:
- complex oral solid dosages (tablets, granules, and capsules)
- liquids (solutions, suspensions, and nasal sprays)
- semi-solids (creams, lotions, and gels)
- pharmaceutical Rx and OTC products for clinical through commercial manufacturing
- serialization and packaging
Bora owns and operates three state-of-the-art cGMP manufacturing facilities in Taiwan and Canada that are built to the highest international standards for manufacturing, packaging, R&D, and analytical testing.
We can handle high potency compounds, solvents, flammables, and IR/SR/ER release profile products.
Our Taiwanese facilities are USFDA, MHRA, TFDA, Jordan FDA, and GCC (Gulf Cooperation Council) inspected. Our Mississauga, Canada site is approved by all major regulatory agencies including USFDA, Health Canada, ANVISA, EMA, PDMA, and the Japanese Ministry of Health. Our USFDA audits have had no major findings.
Bora's sites deliver to more than 100 markets around the world including the US/Canada, EU, Southeast Asia, Middle East, and South and Central America. All sites are TAA compliant. Our packaging lines are fully serialized. Our sites have over a 97% on-time delivery record!
Bora Pharmaceuticals has an experienced management team, with an average of over 20+ years working in the pharmaceutical industry.